IndiviDrug
@drugindivi
INDIVIDUALIZED DRUG THERAPY - Research program at @helsinkiuni
ID: 1235906197041172480
https://bit.ly/3EnI3TV 06-03-2020 12:33:51
22 Tweet
49 Followers
34 Following
Check out this thread summarising a very interesting new paper by one of our PI:s, congrats Sinem Karaman 🇺🇦 ! #IndiviDrug #research #vascularbiology
Now online! CPIC guideline for SLCO1B1, ABCG2, and CYP2C9 and statin‐associated musculoskeletal symptoms - Clinical Pharmacology & Therapeutics - Wiley Online Library ASCPT Journal Family ascpt.onlinelibrary.wiley.com/doi/abs/10.100…
Our latest review is out: A closer look at adipose tissue lymphatics and their markers (Current Opinion in Hematology) Congratulations Madeleine Lackman 🇺🇦 and Yelin Subashi 🌍 IndiviDrug University of Helsinki Wihurin rahasto #vascularbiology journals.lww.com/co-hematology/…
Excited to share the paper by talented Anssi Mykkänen et al on simvastatin #pharmacogenomics accepted to #CPTjournal ASCPT Journal Family! TerkkoLib Medicine and Health, University of Helsinki IndiviDrug ascpt.onlinelibrary.wiley.com/doi/abs/10.100…
Great Finnish presence at the poster session of @eacpt 2022 conference in Athens! Suomen Kliinisen Farmakologian Yhdistys IndiviDrug
Happy to share our latest article British Journal of Clinical Pharmacology (BJCP), deciphering the roles of SLCO1B1, ABCG2 and SLCO2B1 PGx in rosuvastatin PK, by talented Minna Lehtisalo and co-workers IndiviDrug Medicine and Health, University of Helsinki! bpspubs.onlinelibrary.wiley.com/doi/abs/10.111…
In addition to amazing research our scientists can also play Mölkky. - congrats teams Moksis and Pölkky! Thanks Applied Tumor Genomics (ATG) for organizing the event.
So proud of our Imaging Rockstar Satu for having not one but two photos in the NikonSmallWorld finalists 🤩! The below photo won third place, the other one is an Image of Distinction IndiviDrug University of Helsinki Medicine and Health, University of Helsinki #WeAreHelsinkiUni #HelsinkiUni tinyurl.com/32efcyv7
Check our new paper characterizing the CYP metabolism and inhibition potential of hydroxychloroquine by Marie-Noëlle Paludetto, Anne Filppula et al. Medicine and Health, University of Helsinki dmd.aspetjournals.org/content/early/…
Novel BCRP inhibitors identified among marketed drugs, with potential for clinically significant drug-drug interactions. New paper by Feng Deng, Heidi Kidron et al. Medicine and Health, University of Helsinki @reltranspmeansd sciencedirect.com/science/articl…
We report three cases of rhabdomyolysis during concomitant use of ticagrelor and rosuvastatin, and propose a mechanism underlying the potential drug-drug interaction. A paper by Minna Lehtisalo & coworkers. IndiviDrug Medicine and Health, University of Helsinki bpspubs.onlinelibrary.wiley.com/doi/10.1111/bc…
Functional characterization of six rare non-synonymous variants in SLCO1B1, a paper by Katja Häkkinen, Wilma Kiander and coworkers. IndiviDrug Medicine and Health, University of Helsinki pubs.acs.org/doi/10.1021/ac…
Wonderfully inspirational talk by Tiina Lindfors at #RPUSciDay2023 A lot to think about on the importance and value of storytelling in art and in science #HelsinkiUni IndiviDrug
Thank you Munir Pirmohamed for a wonderful talk on the future of #pharmacogenomics at the #RPUSciDay2023 University of Helsinki! We need centrally funded implementation in all healthcare sectors, comprehensive education, support for clinicians and further research funding. bps.ac.uk/getmedia/b43a3…